For product 05-636, a good buffer to use is the supplied buffer: 0.1M Tris-Glycine, pH 7.4, 0.15M NaCl, 0.05% sodium azide. This is both the storage and recommended working buffer for this antibody.
Vybrat velikost
| Velikost balení | Skladová položka | Dostupnost | Cena |
|---|---|---|---|
| 25 μg | Očekávané datum odeslání11. května 2026odAreál Kühne+Nagel spol. s r.o. | 4 910,00 Kč | |
| 200 μg | Očekávané datum odeslání11. května 2026odAreál Kühne+Nagel spol. s r.o. | 18 400,00 Kč |
O této položce
4 910,00 Kč
Očekávané datum odeslání11. května 2026podrobné informace
biological source
mouse
Quality Level
antibody form
affinity purified immunoglobulin
clone
JBW301, monoclonal
species reactivity
vertebrates
packaging
antibody small pack of 25 μg
manufacturer/tradename
Upstate®
technique(s)
ChIP: suitable, immunocytochemistry: suitable, immunofluorescence: suitable, immunohistochemistry: suitable, western blot: suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
phosphorylation (pSer139)
General description
Immunogen
Application
Immunohistochemistry Analysis: A representative lot detected Histone H2A.X (pSer139) in RNF168-WT and RNF 168-SA/SEKI mice lung tissue sections (Paraffin). (Xe, X., et al. (2015) Nat. Cell Biol. 20 (3); 320-331).
Chromatin Immunoprecipitation, see Meier, Andreas, et al. EMBO J., 26: 2707-18 (2007) in technical information tab.
Epigenetics & Nuclear Function
Histones
Biochem/physiol Actions
Physical form
Preparation Note
Analysis Note
Immunocytochemistry: 2 μg/ml of this antibody detected phosphorylated histone H2A.X in HeLa cells treated with 0.5 μM staurosporine for 4-6 hours.
UV-treated 293 cell extracts, UV-treated HeLa cell extracts or breast cancer tissue
Other Notes
Legal Information
Disclaimer
1 of 1
Tato položka | |||
|---|---|---|---|
| species reactivity vertebrates | species reactivity human | species reactivity human, rat, mouse | species reactivity human |
| biological source mouse | biological source mouse | biological source mouse | biological source mouse |
| clone JBW301, monoclonal | clone JBW301, monoclonal | clone JBW301, monoclonal | clone JBW301, monoclonal |
| antibody form affinity purified immunoglobulin | antibody form purified immunoglobulin | antibody form purified immunoglobulin | antibody form purified antibody |
| UniProt accession no. | UniProt accession no. | UniProt accession no. | UniProt accession no. |
| technique(s) ChIP: suitable, immunofluorescence: suitable, western blot: suitable, immunocytochemistry: suitable, immunohistochemistry: suitable | technique(s) flow cytometry: suitable, immunocytochemistry: suitable | technique(s) ChIP: suitable, immunocytochemistry: suitable, immunofluorescence: suitable, western blot: suitable | technique(s) immunocytochemistry: suitable, western blot: suitable |
Still not finding the right product?
Explore all of our products under Anti-phospho-Histone H2A.X (Ser139) Antibody, clone JBW301
Skladovací třída
12 - Non Combustible Liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Osvědčení o analýze (COA)
Vyhledejte osvědčení Osvědčení o analýze (COA) zadáním čísla šarže/dávky těchto produktů. Čísla šarže a dávky lze nalézt na štítku produktu za slovy „Lot“ nebo „Batch“.
Již tento produkt vlastníte?
Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.
Sortimentní položky
Protilátky se spojují se specifickými antigeny a vytvářejí exkluzivní komplex protilátka-antigen. Seznamte se s podstatou této vazby a jejím využitím jako molekulární značky pro výzkum.
Zjistěte, jaké jsou rozdíly mezi monoklonálními a polyklonálními protilátkami, včetně způsobu generování protilátek, počtu klonů a formátů protilátek.
Antibodies combine with specific antigens to generate an exclusive antibody-antigen complex. Learn about the nature of this bond and its use as a molecular tag for research.
Související obsah
Find protein research tools to prepare, isolate, and analyze proteins. Organized by how to extract, protect, purify, enrich, modify, and quantify proteins.
"Recognizing both the tremendous opportunities and the challenges facing cancer research, we are dedicated to developing and refining tools and technologies for the study of cancer. With our comprehensive portfolio, including the Upstate®, Chemicon®, and Calbiochem® brands of reagents and antibodies, researchers can count on dependable, high quality solutions for analyzing all the hallmarks of cancer."
Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).
-
hi. The antiboy is in powdered form. Please guide which buffer is best to reconstitute the antibody and the amount of buffer to be used for reconstitution.
1 answer-
Helpful?
-
-
この抗体は何に溶けていますか?
1 answer-
This product is in 0.1M Tris-Glycine, pH 7.4, 0.15M NaCl, 0.05% sodium azide as a preservative.
Helpful?
-
-
Your product quoted in https://doi.org/10.1016/j.mrgentox.2010.05.009 as 1:1000 dilution.if i use 05-636-25UG, how much µg/ml antibody shall I have to use for whole cell ELISA.
1 answer-
For 05-636, we have not studied this internally for ELISA and therefore, do not have suggestions on using this for ELISA.
Helpful?
-



